Novel neoadjuvant treatment strategies for triple-negative breast cancer

Andrew A. Davis; William J. Gradishar

Novel neoadjuvant treatment strategies for triple-negative breast cancer

Research output: Contribution to journal › Article › peer-review

Abstract

Experts review the current landscape and potential use of neoadjuvant chemotherapy with additional novel agents for patients with localized TNBC.

Original language	English
Journal	ONCOLOGY (United States)
Volume	34
Issue number	5
State	Published - May 13 2020

Cite this

@article{489f00e8163e4c2499f7ac68c852e520,

title = "Novel neoadjuvant treatment strategies for triple-negative breast cancer",

abstract = "Experts review the current landscape and potential use of neoadjuvant chemotherapy with additional novel agents for patients with localized TNBC.",

author = "Davis, {Andrew A.} and Gradishar, {William J.}",

year = "2020",

month = may,

day = "13",

language = "English",

volume = "34",

journal = "Oncology (Williston Park, N.Y.)",

issn = "0890-9091",

number = "5",

}

TY - JOUR

T1 - Novel neoadjuvant treatment strategies for triple-negative breast cancer

AU - Davis, Andrew A.

AU - Gradishar, William J.

PY - 2020/5/13

Y1 - 2020/5/13

N2 - Experts review the current landscape and potential use of neoadjuvant chemotherapy with additional novel agents for patients with localized TNBC.

AB - Experts review the current landscape and potential use of neoadjuvant chemotherapy with additional novel agents for patients with localized TNBC.

UR - http://www.scopus.com/inward/record.url?scp=85091593711&partnerID=8YFLogxK

M3 - Article

C2 - 32644178

AN - SCOPUS:85088068833

SN - 0890-9091

VL - 34

JO - Oncology (Williston Park, N.Y.)

JF - Oncology (Williston Park, N.Y.)

IS - 5

ER -

Novel neoadjuvant treatment strategies for triple-negative breast cancer

Abstract

Other files and links

Fingerprint

Cite this